Fernando Carlos Proença

Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects

R. Lôbo, F. Baldi, F. Cadegiani, 2022, Cureus.

Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching

R. Lôbo, F. Baldi, F. Cadegiani, 2022, Cureus.

Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching

Jennifer A. Hibberd, Washington Luiz O Assagra, Fernando Carlos Proença, 2022, Cureus.